Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: A meta-analysis

作者: Deepika Misra , Keith Leibowitz , Ramesh M. Gowda , Michael Shapiro , Ijaz A. Khan

DOI: 10.1002/CLC.4960271106

关键词: MedicineSurgeryContrast-induced nephropathyCreatinineKidney diseaseNephropathyMeta-analysisRelative risk reductionOral administrationSalineUrology

摘要: Background: Contrast-induced nephropathy is one of the common causes acute renal insufficiency after cardiovascular procedures. Hypothesis: The objective this paper was to analyze published data on usefulness N-acetylcysteine in prevention contrast-induced these procedures. Methods: Trials were selected if they prospective, randomized, controlled, had patients with impaired function, used low-osmolality, nonionic contrast media intra-arterially, administered a total four doses N-acetyl-cysteine addition intravenous saline hydration, and as their primary outcome. defined an increase serum creatinine concentration by > 0.5 mg/dl or 25% above baseline at within 48 h post procedure. Meta-analysis performed using Fisher's Combined Test measure effect size. magnitude estimated random-effects models. Homogeneity evaluated chi-square test homogeneity standard Q statistic. Reporting bias explored Rosenthal method. Results: significant p < 0.005 favor N-acetylcysteine. size reduce 20%. There 62% relative risk reduction fixed-effects model, 70% model. In addition, we found that 27 unpublished trials showing no effects would exist overturn combined significance five our meta-analysis. Conclusion: Oral administration hydration has beneficial procedures function.

参考文章(18)
Gregg B. Jackson, John E. Hunter, Frank L. Schmidt, Meta-Analysis: Cumulating Research Findings Across Studies ,(1982)
Jay Kay, Wing Hing Chow, Tak Mao Chan, Sing Kai Lo, On Hing Kwok, Alex Yip, Katherine Fan, Chi Hang Lee, Wai Fai Lam, Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. ,vol. 289, pp. 553- 558 ,(2003) , 10.1001/JAMA.289.5.553
J. M. Burgunder, A. Varriale, B. H. Lauterburg, Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. European Journal of Clinical Pharmacology. ,vol. 36, pp. 127- 131 ,(1989) , 10.1007/BF00609183
Peter Aspelin, Pierre Aubry, Sven-Göran Fransson, Ruth Strasser, Roland Willenbrock, Knut Joachim Berg, Nephrotoxic effects in high-risk patients undergoing angiography The New England Journal of Medicine. ,vol. 348, pp. 491- 499 ,(2003) , 10.1056/NEJMOA021833
Peter A McCullough, Robert Wolyn, Leslie L Rocher, Robert N Levin, William W O’Neill, Acute Renal Failure After Coronary Intervention: Incidence, Risk Factors, and Relationship to Mortality The American Journal of Medicine. ,vol. 103, pp. 368- 375 ,(1997) , 10.1016/S0002-9343(97)00150-2
Suhail Allaqaband, Ramagopal Tumuluri, Ahmed M Malik, Anjan Gupta, Paul Volkert, Yoseph Shalev, Tanvir K Bajwa, None, Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheterization and Cardiovascular Interventions. ,vol. 57, pp. 279- 283 ,(2002) , 10.1002/CCD.10323
Christopher S.R Baker, Andrew Wragg, Sanjay Kumar, Rodney De Palma, Laurence R.I Baker, Charles J Knight, A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. Journal of the American College of Cardiology. ,vol. 41, pp. 2114- 2118 ,(2003) , 10.1016/S0735-1097(03)00487-X
H. Zhang, H. Spapen, D.N. Nguyen, P. Rogiers, J. Bakker, J.L. Vincent, Effects of N-Acetyl-L-Cysteine on Regional Blood Flow during Endotoxic Shock European Surgical Research. ,vol. 27, pp. 292- 300 ,(1995) , 10.1159/000129412
Neil P Andrews, Abhiram Prasad, Arshed A Quyyumi, N-acetylcysteine improves coronary and peripheral vascular function Journal of the American College of Cardiology. ,vol. 37, pp. 117- 123 ,(2001) , 10.1016/S0735-1097(00)01093-7